STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
19.90
-0.42 (-2.07%)
At close: Feb 27, 2026, 4:00 PM EST
19.85
-0.05 (-0.25%)
After-hours: Feb 27, 2026, 7:25 PM EST
STAAR Surgical Company Revenue
STAAR Surgical Company had revenue of $94.73M in the quarter ending September 26, 2025, with 6.93% growth. This brings the company's revenue in the last twelve months to $230.59M, down -32.42% year-over-year. In the year 2024, STAAR Surgical Company had annual revenue of $313.90M, down -2.64%.
Revenue (ttm)
$230.59M
Revenue Growth
-32.42%
P/S Ratio
4.29
Revenue / Employee
$199,301
Employees
1,157
Market Cap
989.86M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 27, 2024 | 313.90M | -8.51M | -2.64% |
| Dec 29, 2023 | 322.42M | 38.02M | 13.37% |
| Dec 30, 2022 | 284.39M | 53.92M | 23.40% |
| Dec 31, 2021 | 230.47M | 67.01M | 41.00% |
| Jan 1, 2021 | 163.46M | 13.28M | 8.84% |
| Jan 3, 2020 | 150.19M | 26.23M | 21.16% |
| Dec 28, 2018 | 123.95M | 33.34M | 36.80% |
| Dec 29, 2017 | 90.61M | 8.18M | 9.92% |
| Dec 30, 2016 | 82.43M | 5.31M | 6.88% |
| Jan 1, 2016 | 77.12M | 2.14M | 2.85% |
| Jan 2, 2015 | 74.99M | 2.77M | 3.84% |
| Jan 3, 2014 | 72.22M | 8.43M | 13.22% |
| Dec 28, 2012 | 63.78M | 1.02M | 1.62% |
| Dec 30, 2011 | 62.77M | 7.81M | 14.21% |
| Dec 31, 2010 | 54.96M | 3.90M | 7.63% |
| Jan 1, 2010 | 51.06M | 1.29M | 2.59% |
| Jan 2, 2009 | 49.77M | -9.59M | -16.16% |
| Dec 28, 2007 | 59.36M | 2.41M | 4.24% |
| Dec 29, 2006 | 56.95M | 5.65M | 11.01% |
| Dec 30, 2005 | 51.30M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DENTSPLY SIRONA | 3.62B |
| Embecta | 1.08B |
| Azenta | 595.03M |
| AtriCure | 534.53M |
| AngioDynamics | 307.31M |
| LeMaitre Vascular | 249.60M |
| BioLife Solutions | 100.14M |
| Kestra Medical Technologies | 74.26M |
STAA News
- 3 days ago - STAAR Surgical Surpasses 4 Million ICLs Sold Globally, Reflecting Ongoing Shift Away from Laser-Based Vision Correction - Business Wire
- 5 days ago - STAAR Surgical to Host Fourth Quarter and Fiscal Year 2025 Earnings Conference Call and Webcast on March 3, 2026 - Business Wire
- 11 days ago - FDA Expands U.S. Age Indication for EVO ICL as Long-Term Safety Data Reinforces Market Shift Away From Laser Vision Correction - Business Wire
- 26 days ago - STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs - Business Wire
- 6 weeks ago - STAAR Surgical Stock Falls After Largest Shareholder Broadwood Gains Board Influence - Benzinga
- 6 weeks ago - STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement - Business Wire
- 7 weeks ago - Alcon Terminates Agreement to Acquire STAAR Surgical - Business Wire
- 7 weeks ago - STAAR Surgical Merger With Alcon Fails After Shareholders Vote No - Benzinga